Cipla, country's second-largest pharmaceuticals company, is in discussion with an international health group to expand its contraceptive pills market. The company has held preliminary talks with London-based International Planned Parenthood, an organization that promotes sexual and reproductive health, for supplying drugs in Africa and South Asian countries and collaborating in research in the contraceptives segment.
The company is planning to market these contraceptive drugs in developing countries as per the demands of non-government organizations and aid groups, such as International Planned Parenthood Federation (IPPF). It is also looking for an international market as contraceptive drugs are subject to stringent regulations to prevent misuse in India. Advertisement of these medicines is prohibited and drug manufacturers have to maintain records.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1625.55 |
| Dr. Reddys Lab | 1337.60 |
| Cipla | 1300.65 |
| Zydus Lifesciences | 930.65 |
| Lupin | 2280.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: